Lisa Fleming
Research Data Analyst 2
Medicine
School of Medicine

Publications (3)

Top publication keywords:
HIV Infectionssrc-Family KinasesViral LoadBreast NeoplasmsCapillary PermeabilityReceptors, Vascular Endothelial Growth FactorNeovascularization, PathologicMice, NudeSafety-net ProvidersMagnetic Resonance ImagingSan FranciscoRetrospective StudiesAnti-HIV AgentsImidazolesIndazoles

• Trends in HIV Viral Suppression in the POP-UP Low-Barrier Care Program for People With HIV Experiencing Homelessness or Unstable Housing.
  Open forum infectious diseases 2026 Imbert E, Fleming L, Oskarsson J, Cullen C, Shiels M, Friend J, Jackson J, Felten L, Zahedikia N, Montgomery F, Santos L, Mayorga-Munoz F, Rodriguez Y, Breganza Y, Grochowski J, Cohen J, Appa A, …
• Outcomes of Rapid Restart Among People With Previously Diagnosed HIV at a Safety-Net HIV Clinic in San Francisco.
  Journal of acquired immune deficiency syndromes (1999) 2025 Salazar J, Coffey S, Bloome J, Hickey MD, Fleming L, Franco S, Suarez A, Havlir D, Sauceda JA, Gandhi M, Christopoulos KA
• AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
  Magnetic resonance imaging 2007 Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM